This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Fundación Instituto De Investigación Sanitaria De Santiago De Compostela (Fidis), Servizo Galego De Saude, Universidade De Santiago De Compostela. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2024
Title: Cristobal Colón Mejeras: Innovator in Nanostructured Lipid Systems
Introduction
Cristobal Colón Mejeras is a notable inventor based in Santiago de Compostela, Spain. He has made significant contributions to the field of enzyme replacement therapy through his innovative work on nanostructured lipid systems. His research focuses on improving the administration of enzymes or other proteins, particularly for the treatment of lysosomal diseases.
Latest Patents
Cristobal Colón Mejeras holds a patent for a nanostructure lipid system. This invention relates to systems for administering enzymes or proteins, specifically designed for enzyme replacement therapy. The patent encompasses the preparation of a composition based on nanostructured lipid systems and its application in manufacturing therapeutic products.
Career Highlights
Throughout his career, Cristobal has worked with esteemed institutions such as the University of Santiago de Compostela and the Servizo Galego de Saúde. His work in these organizations has allowed him to advance his research and contribute to the medical field significantly.
Collaborations
Cristobal has collaborated with notable colleagues, including José Víctor Álvarez González and Francisco Javier Otero Espinar. These partnerships have enriched his research and expanded the impact of his innovations.
Conclusion
Cristobal Colón Mejeras is a pioneering inventor whose work in nanostructured lipid systems has the potential to transform enzyme replacement therapy. His contributions to the field highlight the importance of innovation in addressing complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile